Clinical Trial Update: CO2 (Carbon Dioxide) - Cerebral Oxygenation [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing inhaled carbon dioxide for improving cerebral oxygenation in brain hypoxia has completed, sponsored by the University of Zurich.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Hypoxia

Drugs mentioned

• CARBON DIOXIDE (CARBON DIOXIDE)

Snippet

Sponsor: University of Zurich | Conditions: Hypoxia, Brain | Phase 2 | Status: COMPLETED